Shares Investor Evening (Manchester), 10 October 2019

Looking for new companies to invest in? Join Shares Magazine and AJ Bell Media at their evening event in Manchester.
The event will include:

  • Presentations from Directors of companies to be announced
  • An opportunity for you to talk directly with the Directors and ask your questions about the company’s core strengths and their short & long term business strategy
  • Meet fellow investors and share your investing experience
  • Complimentary drinks and food

More about the companies presenting:

Belvoir Lettings – (BLV) – Belvoir Lettings is uniquely positioned within the property sector, benefiting from the agility of a franchise business model compared with the larger corporate players, whilst providing our networks with the Central Office systems and support, not available to the smaller independent agents

Mercia Technologies – (MERC) – Mercia is a national investment group focused on the funding and scaling of innovative technology businesses with high growth potential from the UK regions. Mercia benefits from 19 university partnerships and offices across the Midlands, the North of England and Scotland providing it with access to high quality, regional deal flow.

ReNeuron Group – (RENE) – ReNeuron Group is a leading, clinical-stage stem cell business. Our primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.

SkinBio Therapeutics – (SBTX) – SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CEO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.The business strategy is to partner and outlicense its programmes at proof of concept.

VolitionRx – (VNRX) – VolitionRx is a multi-national life sciences company developing simple, easy to use blood-based cancer tests to accurately diagnose a range of cancers. The tests are based on the science of Nucleosomics®, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid – an indication that disease is present.

Go here for further details and to register

Get more stuff

Subscribe to our events and get updates to your email inbox

Thank you for subscribing.

Something went wrong.